Integrating SEND outcomes in IND-enabling studies

SEND (Standard for Exchange of Nonclinical Data) describes a structured way to submit nonclinical data in a consistent format to U.S. Food and Drug Administration (FDA). SEND aims to improve the efficiency and quality of the Investigative New Drug (IND) and New Drug Application (NDA) processes.

SEND-export

SEND submission is now mandatory for single dose toxicity, repeat-dose toxicity, carcinogenicity, cardiovascular and respiratory studies.  However, the flexible interpretation of these guidelines and resulting variability in the output datasets1 can cause delays and inefficiencies in the review process.

As an industry partner with deep expertise in IND-enabling studies, emka TECHNOLOGIES helps nonclinical scientists comply with SEND requirements by generating SEND 3.1 compatible tables directly from emka TECHNOLOGIES software.

The data can easily be exported to .xls, .csv and integrated into third-party solutions by Instem and Xybion to increase productivity in preclinical studies.

 

Main features
  • Selection of SEND variables for each domain
  • Semi-automatic population of the domains wherever possible.
  • Choice lists available with the full CDISC terminology
  • Management of the format codes from the implementation guide
  • Preview SEND-formatted data ready to be exported as .xls or .csv files
  • No need to re-validate your acquisition system. SEND export module works with any
    IOX version.

References

Empowering researchers

Welcome to emka’s knowledge center. You can find everything you need to get most out of your emka TECHNOLOGIES system.

By browsing this website, you accept the use of cookies for statistical purposes.

Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are set through our site by our advertising partners.

We use Adwords to track our Conversions through Google Clicks.

We use Hubspot to monitor our traffic and to help us AB test new features.